PakVac, Pakistan’s first locally-packaged single-dose COVID-19 vaccine, is now acceptable in the US and UK, SAPM on Health, Dr. Faisal Sultan, has revealed.
While speaking on a talk show, Dr. Faisal Sultan clarified that PakVac is acceptable in all those countries, including the US and UK, that do not require inbound travelers to be vaccinated with certain Coronavirus vaccines.
Also known as Ad5-nCoV, PakVac is a rebranded version of a Chinese single-dose Coronavirus vaccine that was originally developed by CanSinoBIO in collaboration with the Beijing Institute of Biotechnology.
Read more: Pakistan produces COVID vaccine: PakVac
The vaccine was tested in large-scale phase-III clinical trials that were held in five countries, including Pakistan, in which more than 40,000 volunteers participated.
Results of trials were published in February this year which confirmed that the CanSinoBIO vaccine was 65% effective at preventing symptomatic cases and 91% effective at preventing severe infection. As for the Pakistani subset, the vaccine offered 75% protection against symptomatic cases and 100% protection against severe infection.
#PakVac, #Pakistan’s first locally-packaged single-dose #COVID19 vaccine, is acceptable in the #US and #UK. The vaccine was tested in large-scale phase-III clinical trials that were held in five countries, in which more than 40,000 volunteers participated.https://t.co/e96FxHU0Dg
— Qasim Khan Suri (@QasimKhanSuri) July 21, 2021
In May, the National Institute of Health (NIH) Islamabad launched the local packaging of PakVac after its raw material reached Pakistan from China.
NIH is preparing 3 million doses of PakVac each month that has significantly reduced Pakistan’s dependence on imported COVID-19 vaccines and ensured the sufficient availability of the Coronavirus vaccine.
Despite being the fifth largest internal market, Pakistan lags far behind in the biopharmaceutical industry that comprises vaccines and high-cost recombinant biological drugs.
It imports all its vaccines, and produces only a few antisera such as rabies and snake venom, based on simple technology that has been around for decades. No modern vaccines or any other biological products are produced from scratch in Pakistan.